PUBLISHER: Grand View Research | PRODUCT CODE: 1433556
PUBLISHER: Grand View Research | PRODUCT CODE: 1433556
The global veterinary excipients market size is expected to reach USD 1.49 billion by 2030, registering a CAGR of 4.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth is driven by increasing complexity of formulations, sourcing of ingredients from third-party manufacturers, growing importance of animal health, and initiatives by the key companies.There has been a growing demand for excipients tailored to specific formulations and drug delivery systems in the veterinary sector. This includes formulations or dosage differing for different animal species thus needing specialized formulations. This is also expected to support the market growth.
The market's growth was notably impeded by a slowdown in growth rate due to supply chain hurdles and limited access to veterinary care. It was further impacted by the macroeconomic headwinds of 2022. Croda International Plc, for example, reported an increase of about 23% for its raw material costs in 2022. The company also reported increase in operating costs such as energy and labor. However, as the underlying drivers such as advancements in veterinary medicine and its demand remain unchanged, the market is expected to grow significantly over the forecast period.
Technological advancements enabling the development of more sophisticated excipients with enhanced functionalities. For instance, excipients that improve the bioavailability of drugs or facilitate controlled-release formulations. There has also been an increasing preference for natural and organic excipients in veterinary medicine. Also, with the rise of biopharmaceuticals in both human and veterinary medicine, there is a growing need for excipients suitable for these complex formulations. This includes excipients that can stabilize and enhance the delivery of biologically derived drugs. All of these factors support market growth.